Long-term safety and efficacy of ivacaftor in patients with cystic fibrosis who have the Gly551Asp-CFTR mutation: a phase 3, open-label extension study (PERSIST).
primary studies published RCT
Details- 2014
- McKone EF
Costs of Bronchoalveolar Lavage-Directed Therapy in the First 5 Years of Life for Children with Cystic Fibrosis.
primary studies published RCT
Details- 2014
- Moodie M
Pancreatic enzyme supplementation improves the incretin hormone response and attenuates postprandial glycaemia in adolescents with cystic fibrosis: a randomized crossover trial.
primary studies published RCT
Details- 2014
- Perano SJ
Exercise programme in patients with cystic fibrosis: A randomized controlled trial.
primary studies published RCT
Details- 2014
- Rovedder PM
Comparison of two tobramycin nebuliser solutions: pharmacokinetic, efficacy and safety profiles of T100 and TNS.
primary studies published RCT
Details- 2014
- Sands D
The effect of short-term, high-dose oral N-acetylcysteine treatment on oxidative stress markers in cystic fibrosis patients with chronic P. aeruginosa infection - A pilot study.
primary studies published RCT
Details- 2014
- Skov M
Osteopathic manipulative treatment for inpatients with pulmonary exacerbations of cystic fibrosis: effects on spirometry findings and patient assessments of breathing, anxiety, and pain.
primary studies published RCT
Details- 2014
- Swender DA
Clarithromycin therapy for patients with cystic fibrosis: a randomized controlled trial.
primary studies published RCT
Details- 2013
A randomized placebo-controlled study on high-dose oral algal docosahexaenoic acid supplementation in children with cystic fibrosis.
primary studies published RCT
Details- 2013
- Alicandro G
Inhaled aztreonam lysine vs. inhaled tobramycin in cystic fibrosis: A comparative efficacy trial.
primary studies published RCT
Details- 2013
- Assael BM